Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2007
10/25/2007US20070249832 For agriculture crops
10/25/2007US20070249707 Taxanes having c7 hydroxy and c10 heterosubstituted acetate substituents
10/25/2007US20070249701 Cyclic amine CCR5 receptor antagonists
10/25/2007US20070249698 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders
10/25/2007US20070249691 Mercaptoimidazoles as Ccr2 Receptor Antagonists
10/25/2007US20070249684 Solid Forms of the Magnesium Salt of S-Omeprazole and Processes for Their Preparation
10/25/2007US20070249683 Dicarboxamide derivatives
10/25/2007US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
10/25/2007US20070249679 inhibitor of serotonin reuptake transporter protein; as tachykinin antagonists treating nervous system disorders, psychological disorders, rheumatoid arthritis; 1-[(3,5-dichlorophenyl)methyl]-3-[4-(4-fluorophenyl)-1-methyl-4-piperidinyl]-1,3-dihydro-2H-imidazol-2-one; cyclization preparation
10/25/2007US20070249676 Cyanoguanidine prodrugs
10/25/2007US20070249665 1-aryl-4-substituted isoquinolines
10/25/2007US20070249629 Viral Polymerase Inhibitors
10/25/2007US20070249623 1-(Indole-6-Carbonyl-D-Phenylglycinyl)-4-(1-Methylpiperidin-4-Yl)Piperazine D-Tartrate
10/25/2007US20070249620 Urea Derivative
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/25/2007US20070249617 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders
10/25/2007US20070249607 Nk-1 and serotonin transporter inhibitors
10/25/2007US20070249604 3-Monosubstituted tropane derivatives as nociceptin receptor ligands
10/25/2007US20070249603 3-Arylsulfonyl-Quinolines as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders
10/25/2007US20070249602 Abnormal Cannabidiols as agents for lowering intraocular pressure
10/25/2007US20070249601 Compounds and therapeutical use thereof
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007US20070249578 New amidino derivatives and their use as thrombin inhibitors
10/25/2007CA2649161A1 Cgrp antagonist salt
10/25/2007CA2649146A1 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
10/25/2007CA2648892A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648891A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648555A1 Diaryl substituted alkanes
10/25/2007CA2648140A1 New crystalline compounds
10/25/2007CA2645961A1 Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
10/25/2007CA2644979A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/24/2007EP1847539A1 Quinazoline derivatives
10/24/2007EP1847538A1 A process for the preparation of pyridine compounds
10/24/2007EP1847537A1 Dicarboxamide derivatives
10/24/2007EP1847536A1 Synthesis and uses of pyroglutamic acid derivatives
10/24/2007EP1847535A1 1-(piperidin-4-yl)-1h-indole derivative
10/24/2007EP1847532A1 Igf-1r inhibitor
10/24/2007EP1847531A1 Pyrazole compound
10/24/2007EP1846398A1 Alkinyl-oxypyrimidine used in the form of pesticides
10/24/2007EP1846395A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
10/24/2007EP1846394A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/24/2007EP1846393A2 4-(2,6-dichlorobenzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
10/24/2007EP1846392A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
10/24/2007EP1846391A2 Raf inhibitor compounds and methods
10/24/2007EP1846390A1 Novel 6-pyridylphenanthridines
10/24/2007EP1846389A1 Imidazole derivatives
10/24/2007EP1846381A2 Novel heteroarylacetamides
10/24/2007EP1846372A2 Compounds for inflammation and immune-related uses
10/24/2007EP1845991A2 Substituted 5-phenyl pyrimidines i in therapy
10/24/2007EP1587788B9 2,7-substituted indoles and their use as 5-ht6 modulators
10/24/2007EP1424334B1 Quinazolinone derivative
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
10/24/2007CN101061119A Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease
10/24/2007CN101061110A Novel insecticides
10/24/2007CN101061109A Novel pyridonecarboxylic acid derivatives or salts thereof
10/24/2007CN101061108A New 4-benzimidazolyl-3(2h)-pyridazinone derivatives are kinase inhibitors, especially useful for treatment of cancer
10/24/2007CN101061107A Amorphous object of cinnamide compound
10/24/2007CN101061106A Potentiators of glutamate receptors
10/24/2007CN101061105A Potentiators of glutamate receptors
10/24/2007CN101061104A Piperidinyl piperidine tachykinin receptor antagonists
10/24/2007CN101061103A Anthranilamide insecticides
10/24/2007CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101061097A Novel gamma secretase inhibitors
10/24/2007CN101060842A Chemical compounds
10/24/2007CN101058571A A process for the preparation of pyridine compounds
10/24/2007CN101058561A Diphenylurea derivative for inhibiting protein kinase, and composition and use thereof
10/24/2007CN100344624C Pharmaceutical preparations containing arginine amides
10/23/2007US7285680 β-alanine derivatives and the use thereof
10/23/2007US7285668 At a concentration of 0.1-0.5 g/ml. at 0-35 degrees C. from a C1-4 alkyl acetate solution; preservation stability
10/23/2007US7285663 Bis(pyrimidinylidene)bisisoindolylidenes, e.g., 3,3'-Bis(1,3-diethyl-2-thio-4,6-dioxotetrahydropyrimidin-5-ylidene)-[1,1']biisoindolylidene and 3,3'-Bis(1,3-dimethyl-2,4,6-trioxotetrahydropyrimidin-5-ylidene)-[1,1']biisoindolylidene; uses include ink-jet printing, color filters and optical storage media
10/23/2007US7285662 Therapeutic heterocyclic compounds
10/23/2007US7285565 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-trifluoromethylphenoxy)1-aminoisoquinoline; and 3-hydroxycarbonyl-2-(4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenoxynaphthalene; highly selective
10/23/2007US7285564 Muscarinic M2 receptor antagonists; such as 4-{N-[7-(3-1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(isopropyl)amino}-1-(4-methoxypyrid-3-ylmethyl)piperidine; reduced blurred vision, constipation and dry mouth side effects
10/23/2007US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1)
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285557 For therapy of obesity, diabetes, depression, or anxiety in a mammal
10/23/2007US7285554 Pyrazole derivative
10/23/2007US7285553 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
10/23/2007US7285551 For use as therapeutic agent and prophylactic agent for hepatitis C
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/23/2007US7285545 N-Pyridyl-7-substituted-2-indolecarboxamides, e.g., 1-Methyl-7-[2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yloxy]-1H-indole-2-carboxylic acid (2-tert-butyl-5-methoxy-pyridin-4-yl)-amide; used to treat chronic inflammatory diseases
10/23/2007CA2406849C Stabilized liquid preparation
10/23/2007CA2295088C Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates
10/21/2007CA2585602A1 A process for the preparation of pyridine compounds
10/18/2007WO2007118185A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/18/2007WO2007118137A1 Benzamide derivatives as inhibitors of histone deacetylase
10/18/2007WO2007117982A2 Organic compounds
10/18/2007WO2007117607A2 Quinazolines for pdk1 inhibition
10/18/2007WO2007117559A2 Renin inhibitors
10/18/2007WO2007117482A2 Renin inhibitors
10/18/2007WO2007117413A1 Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/18/2007WO2007117165A1 New pharmaceutical compounds
10/18/2007WO2007117161A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007WO2007116313A2 Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
10/18/2007WO2007116230A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
10/18/2007WO2007116092A1 Enzyme inhibitors
10/18/2007WO2007116079A1 2-(pyridin-2-yl)-pyrimidines for use as fungicides
1 ... 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 ... 1080